Literature DB >> 30958597

Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.

Dorota W Kulesza1,2, Piotr Przanowski1, Bozena Kaminska1,2.   

Abstract

Transcription factor signal transducer and activator of transcription 3 (STAT3) is constitutively activated in many cancers, including melanomas. Active, phosphorylated STAT3 contributes to tumor growth and formation of the immunosuppressive tumor microenvironment. Recent evidence suggests an important role of STAT3 in self-renewal of cancer stem-like cells (CSCs). In the present study, we aimed to determine the expression and role of active STAT3 in melanoma CSCs. We found the increased levels of phosphorylated (Y705) STAT3 in CSC sphere cultures derived from three human and murine melanoma cells. Knockdown of STAT3 did not affect basal proliferation, but reduced sphere forming capacity of two human melanoma cell lines. Moreover, the level of active STAT3 was elevated in rhodamine 123 negative subpopulations of CSCs sorted from three melanoma cell lines. We found that focal adhesion kinase (FAK) and AKT signaling pathways, implicated in the regulation of cell migration and invasion, were up-regulated in melanoma CSCs. Moreover, expression of SERPINA3, which regulates melanoma invasion, was increased in melanoma CSCs sphere cultures, which correlated with augmented cell invasion in Matrigel. Our findings show that STAT3 is activated and supports maintenance of melanoma CSCs. It suggests that STAT3 could serve as a potential target to impair tumor progression or recurrence.
© 2019 International Federation for Cell Biology.

Entities:  

Keywords:  SERPINA3; cancer stemness; melanoma invasion; melanoma stem-like cells; transcription factor STAT3

Mesh:

Substances:

Year:  2019        PMID: 30958597     DOI: 10.1002/cbin.11134

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  4 in total

Review 1.  Regulation of cancer stem cells in triple negative breast cancer.

Authors:  Norman Fultang; Madhuparna Chakraborty; Bela Peethambaran
Journal:  Cancer Drug Resist       Date:  2021-06-19

2.  STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.

Authors:  Alexander Swoboda; Robert Soukup; Oliver Eckel; Katharina Kinslechner; Bettina Wingelhofer; David Schörghofer; Christina Sternberg; Ha T T Pham; Maria Vallianou; Jaqueline Horvath; Dagmar Stoiber; Lukas Kenner; Lionel Larue; Valeria Poli; Friedrich Beermann; Takashi Yokota; Stefan Kubicek; Thomas Krausgruber; André F Rendeiro; Christoph Bock; Rainer Zenz; Boris Kovacic; Fritz Aberger; Markus Hengstschläger; Peter Petzelbauer; Mario Mikula; Richard Moriggl
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

3.  Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.

Authors:  Xueni Liu; Jianhui Huang; Yanru Xie; Yuefen Zhou; Renyi Wang; Jian Lou
Journal:  Med Sci Monit       Date:  2019-11-24

4.  Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers.

Authors:  Anna Kusienicka; Karolina Bukowska-Strakova; Maciej Cieśla; Witold Norbert Nowak; Iwona Bronisz-Budzyńska; Agnieszka Seretny; Monika Żukowska; Mateusz Jeż; Rościsław Krutyhołowa; Hevidar Taha; Neli Kachamakova-Trojanowska; Halina Waś; Claudine Kieda; Alicja Józkowicz
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.